Erkan Alpsoy, Sena Akanlar, Samir Naghiyev, Dorra Bouazzi, Caner Vardar, Oğuz Yılmaz, Robin Christensen, Gregor B E Jemec
{"title":"土耳其安塔利亚地区化脓性汗腺炎的流行情况。","authors":"Erkan Alpsoy, Sena Akanlar, Samir Naghiyev, Dorra Bouazzi, Caner Vardar, Oğuz Yılmaz, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000542480","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) prevalence studies show considerable regional discrepancies due to various methodological and/or ethnic factors. The prevalence of HS in Türkiye has yet to be examined. This study aimed to assess the HS prevalence with a validated screening questionnaire in Antalya-Türkiye as part of the major project to determine the global prevalence of HS.</p><p><strong>Methods: </strong>This single-center, cross-sectional study in a tertiary health institution was conducted among healthy volunteer adults accompanying patients in the internal medicine outpatient clinics of Akdeniz University between July and November 2022.</p><p><strong>Results: </strong>The study included 1,012 participants, 544 females, and 468 males. Seven participants (4 females and 3 males, median age 44.0 [IQR 40.5-54.5] years old) had HS, and the prevalence was 0.69% (95% confidence interval [0.33%-1.4%]). The proportion of HS at an early stage was higher than the rate previously reported from the same center in a registry research (Hurley I, 28.57% vs 16%). The examination of 110 screen-negative participants did not reveal any HS. There was no difference between HS patients and non-HS participants regarding gender, age, BMI, and daily smoking rate.</p><p><strong>Conclusion: </strong>HS prevalence in Antalya seems compatible with the global prevalence of the disease. This study did not confirm the male dominance observed in Türkiye in earlier studies. The HS patients diagnosed in the study represent a milder spectrum of the disease.</p>","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-4"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233956/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Hidradenitis Suppurativa in Antalya, Türkiye.\",\"authors\":\"Erkan Alpsoy, Sena Akanlar, Samir Naghiyev, Dorra Bouazzi, Caner Vardar, Oğuz Yılmaz, Robin Christensen, Gregor B E Jemec\",\"doi\":\"10.1159/000542480\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Hidradenitis suppurativa (HS) prevalence studies show considerable regional discrepancies due to various methodological and/or ethnic factors. The prevalence of HS in Türkiye has yet to be examined. This study aimed to assess the HS prevalence with a validated screening questionnaire in Antalya-Türkiye as part of the major project to determine the global prevalence of HS.</p><p><strong>Methods: </strong>This single-center, cross-sectional study in a tertiary health institution was conducted among healthy volunteer adults accompanying patients in the internal medicine outpatient clinics of Akdeniz University between July and November 2022.</p><p><strong>Results: </strong>The study included 1,012 participants, 544 females, and 468 males. Seven participants (4 females and 3 males, median age 44.0 [IQR 40.5-54.5] years old) had HS, and the prevalence was 0.69% (95% confidence interval [0.33%-1.4%]). The proportion of HS at an early stage was higher than the rate previously reported from the same center in a registry research (Hurley I, 28.57% vs 16%). The examination of 110 screen-negative participants did not reveal any HS. There was no difference between HS patients and non-HS participants regarding gender, age, BMI, and daily smoking rate.</p><p><strong>Conclusion: </strong>HS prevalence in Antalya seems compatible with the global prevalence of the disease. This study did not confirm the male dominance observed in Türkiye in earlier studies. The HS patients diagnosed in the study represent a milder spectrum of the disease.</p>\",\"PeriodicalId\":11185,\"journal\":{\"name\":\"Dermatology\",\"volume\":\" \",\"pages\":\"1-4\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233956/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000542480\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542480","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
摘要:化脓性汗腺炎(HS)患病率研究显示,由于各种方法学和/或种族因素,存在相当大的区域差异。目前尚不清楚基耶病毒的流行情况。作为确定全球HS患病率的主要项目的一部分,本研究旨在通过安塔利亚- 基耶省有效的筛查问卷评估HS患病率。方法:这项单中心横断面研究于2022年7月至11月在Akdeniz大学内科门诊的健康成人志愿者中进行。结果:该研究包括1012名参与者,544名女性和468名男性。7名参与者(女性4名,男性3名,中位年龄44.0 [IQR 40.5-54.5]岁)患有HS,患病率为0.69%(95%可信区间[0.33%-1.4%])。早期HS的比例高于以前同一中心的登记研究报告(Hurley I, 28.57% vs 16%)。对110名筛查阴性参与者的检查未发现任何HS。HS患者和非HS参与者在性别、年龄、BMI和每日吸烟率方面没有差异。结论:安塔利亚市HS流行情况与全球HS流行情况一致。这项研究并没有证实早期研究中观察到的男性在 rkiye中的优势。研究中诊断出的HS患者代表了一种较轻的疾病谱。
Prevalence of Hidradenitis Suppurativa in Antalya, Türkiye.
Introduction: Hidradenitis suppurativa (HS) prevalence studies show considerable regional discrepancies due to various methodological and/or ethnic factors. The prevalence of HS in Türkiye has yet to be examined. This study aimed to assess the HS prevalence with a validated screening questionnaire in Antalya-Türkiye as part of the major project to determine the global prevalence of HS.
Methods: This single-center, cross-sectional study in a tertiary health institution was conducted among healthy volunteer adults accompanying patients in the internal medicine outpatient clinics of Akdeniz University between July and November 2022.
Results: The study included 1,012 participants, 544 females, and 468 males. Seven participants (4 females and 3 males, median age 44.0 [IQR 40.5-54.5] years old) had HS, and the prevalence was 0.69% (95% confidence interval [0.33%-1.4%]). The proportion of HS at an early stage was higher than the rate previously reported from the same center in a registry research (Hurley I, 28.57% vs 16%). The examination of 110 screen-negative participants did not reveal any HS. There was no difference between HS patients and non-HS participants regarding gender, age, BMI, and daily smoking rate.
Conclusion: HS prevalence in Antalya seems compatible with the global prevalence of the disease. This study did not confirm the male dominance observed in Türkiye in earlier studies. The HS patients diagnosed in the study represent a milder spectrum of the disease.
期刊介绍:
Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.